UNSPSC 51401547: Razobazam

This classification denotes a sedative, hypnotic, and anxiolytic with the molecular formula C14H14N4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LZ84VWN0U4, chemically known as 4,8-dihydro-3,8-dimethyl-4-phenylpyrazolo(3,4-b)(1,4)diazepine-5,7(1h,6h)-dione but generally known as razobazam, which bears US NIH Compound Identifier 71228. European Medicines Agency schedules Razobazam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10265MIG.

UNSPSC 51401547 Razobazam, a Commodity code, encompasses naloxone, drug deactivation systems, generic pharmaceuticals, and over-the-counter products that state and local governments procure to support community health initiatives, pharmacy benefit programs, and emergency response capabilities. State and local buyers—including county health departments, state health and human services agencies, and multistate cooperative purchasing alliances—solicit these products through competitive bidding and request-for-proposal processes. Vendors typically must demonstrate compliance with FDA requirements, current Good Manufacturing Practices, Drug Supply Chain Security Act standards, and federal workplace eligibility verification; maintain specific insurance coverages; and commit to established distribution channels through authorized wholesalers or direct delivery to government facilities.

Activity under this code spans Florida, Texas, and Minnesota, with recent opportunities showing both direct procurement and cooperative purchasing models. Seminole County, Florida issued IFB 60459723LAS (due July 26, 2026) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to support community health initiatives. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026 to gather vendor capabilities for implementing a direct-to-manufacturer prescription program for self-insured state employee health plans. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued RFP S1070000015802 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through AmerisourceBergen, Cardinal Health, and Morris & Dickson, with awards effective July 1, 2026 and contracts running two years with optional extensions through June 30, 2028.